Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Hologic's Enterprise Value is $17,124 Mil.
Hologic's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $1,098 Mil. Therefore, Hologic's EV-to-OCF for today is 15.60.
The historical rank and industry rank for Hologic's EV-to-OCF or its related term are showing as below:
HOLX'
s EV-to-OCF Range Over the Past 10 Years
Min: 6.54 Med: 17.37 Max: 1928.07
Current: 15.6
During the past 13 years, the highest EV-to-OCF of Hologic was 1928.07. The lowest was 6.54. And the median was 17.37.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hologic's share price for today is $76.01.
Hologic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.400.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Hologic EV-to-OCF Related Terms
Hologic EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Hologic's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Hologic's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Hologic's EV-to-OCF falls into.
Hologic's current Enterprise Value is $17,124 Mil.
Hologic's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,098 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (HOLX) has a EV-to-OCF of 15.60 as of Aug. 23, 2026. This is 10% below median its historical median of 17.37. Over the past decade, Hologic's EV-to-OCF has ranged from 6.54 to 1,928.07.
Is Hologic's EV-to-OCF too high?
Hologic's current EV-to-OCF of 15.60 is 10% below median its 10-year median of 17.37. Over the past 10 years, this metric has ranged from a low of 6.54 to a high of 1,928.07. The Medical Devices & Instruments industry median EV-to-OCF is 7.73. Hologic's value of 15.60 is 101.8% above this industry median. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's EV-to-OCF compare to WST and COO?
Hologic's EV-to-OCF of 15.60 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-OCF is 7.73. Hologic's value of 15.60 is 101.8% above this benchmark. Historically, Hologic's own EV-to-OCF has ranged from 6.54 to 1,928.07 over the past decade. While the company's 10-year median is 17.37 vs. the industry median of 7.73, Hologic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.73, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hologic's current EV-to-OCF of 15.60 is 101.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hologic's current EV-to-OCF is 15.60, which is 10% below median its own 10-year median of 17.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (HOLX) has a current EV-to-OCF of 15.60. The stock's GF Value™ is $82.05, compared to a current price of $76.01 — trading 7.4% below its estimated fair value. The current EV-to-OCF is 15.60, which is 10% below median its 10-year median of 17.37 and 101.8% above the Medical Devices & Instruments industry median of 7.73. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Hologic (HOLX), the current EV-to-OCF is 15.60 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (HOLX) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of $76.01 is trading 7.4% below its estimated GF Value™ of $82.05.
Key valuation signals for HOLX:
EV-to-OCF: 15.60 (10% below median its 10-year median of 17.37)
GF Value™: $82.05 vs. price of $76.01 (7.4% below fair value)
Industry Position: 101.8% above the Medical Devices & Instruments median
No single metric tells the full story. See the HOLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for HOLX
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HOLX has been successfully added to your 
